Effect of Multivitamin-mineral Supplementation Versus Placebo on Cognitive Function: Results from the Clinic Subcohort of the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) Randomized Clinical Trial and Meta-analysis of 3 Cognitive...

Overview

Journal Am J Clin Nutr

Publisher Elsevier

Specialty Nutritional Sciences

Date 2024 Jan 20

PMID 38244989

Authors

Chirag M Vyas

JoAnn E Manson

Howard D Sesso

Nancy R Cook

Pamela M Rist

Alison Weinberg

M Vinayaga Moorthy

Laura D Baker

Mark A Espeland

Lok-Kin Yeung

Adam M Brickman

Olivia I Okereke

Affiliations

Soon will be listed here.

Abstract

Background: Longer effects of multivitamin-mineral (MVM) supplementation on late-life cognitive function remain untested using in-person, detailed neuropsychological assessments. Furthermore, insufficient evidence exists for healthcare providers to recommend daily MVM supplements to prevent cognitive decline.

Objectives: This study aimed to test MVM effects on cognitive change using in-person, detailed neuropsychological assessments and conduct a meta-analysis within COSMOS (COcoa Supplement and Multivitamin Outcomes Study) cognitive substudies for a robust evaluation of MVM effects on cognition.

Methods: COSMOS is a 2 × 2 factorial trial of cocoa extract (500 mg flavanols/d) and/or a daily MVM supplement for cardiovascular disease and cancer prevention among 21,442 United States adults aged ≥60 y. There were 573 participants in the clinic subcohort of COSMOS (that is, COSMOS-Clinic) who completed all cognitive tests administered at baseline. For the meta-analysis, we included nonoverlapping participants across 3 COSMOS cognitive substudies: COSMOS-Clinic (n = 573); COSMOS-Mind (n = 2158); COSMOS-Web (n = 2472).

Results: In COSMOS-Clinic, we observed a modest benefit of MVM compared with placebo on global cognition over 2 y {mean difference [95% confidence interval (CI)] = 0.06 SD units (SU) (-0.003, 0.13)}, with a significantly more favorable change in episodic memory [mean difference (95% CI) = 0.12 SU (0.002, 0.23)] but not in executive function or attention [mean difference (95% CI) = 0.04 SU (-0.04, 0.11)]. The meta-analysis of COSMOS substudies showed clear evidence of MVM benefits on global cognition [mean difference (95% CI) = 0.07 SU (0.03, 0.11); P = 0.0009] and episodic memory [mean difference (95% CI) = 0.06 SU (0.03, 0.10); P = 0.0007]; the magnitude of effect on global cognition was equivalent to reducing cognitive aging by 2 y.

Conclusions: In COSMOS-Clinic, daily MVM supplementation leads to a significantly more favorable 2-y change in episodic memory. The meta-analysis within COSMOS cognitive substudies indicates that daily MVM significantly benefits both global cognition and episodic memory. These findings within the COSMOS trial support the benefits of a daily MVM in preventing cognitive decline among older adults. This trial was registered at COSMOS-clinicaltrials.gov as NCT02422745, at COSMOS-Mind-clinicaltrials.gov as NCT03035201, and at COSMOS-Web-clinicaltrials.gov as NCT04582617.

Citing Articles

Association of whole blood multi-micronutrients with mild cognitive impairment in Chinese older adults: a matched case-control study.

Wang Z, Cheng C, Duan H, Chen X, Li W, Ma F Eur J Nutr. 2025; 64(3):111.

PMID: 40047966 PMC: 11885343. DOI: 10.1007/s00394-025-03629-6.

Review of Supplements That Patients Commonly Report Using for Dementia.

Frolov A, Wadood A, Kelley B J Clin Med. 2025; 13(24.

PMID: 39768463 PMC: 11727725. DOI: 10.3390/jcm13247541.

Relationships of B12 and Homocysteine with Outcomes in the SURE-PD, SURE-PD3, and STEADY-PDIII Trials.

Christine C, Auinger P, Forti E, Tat L, Cannizzaro N, Mustafa A J Parkinsons Dis. 2024; 14(6):1243-1255.

PMID: 39240650 PMC: 11380300. DOI: 10.3233/JPD-240035.

Multivitamin Use and Mortality Risk in 3 Prospective US Cohorts.

Loftfield E, OConnell C, Abnet C, Graubard B, Liao L, Beane Freeman L JAMA Netw Open. 2024; 7(6):e2418729.

PMID: 38922615 PMC: 11208972. DOI: 10.1001/jamanetworkopen.2024.18729.

References

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

Baker L, Manson J, Rapp S, Sesso H, Gaussoin S, Shumaker S . Effects of cocoa extract and a multivitamin on cognitive function: A randomized clinical trial. Alzheimers Dement. 2022; 19(4):1308-1319. PMC: 10011015. DOI: 10.1002/alz.12767. View

VENTRY I, Weinstein B . The hearing handicap inventory for the elderly: a new tool. Ear Hear. 1982; 3(3):128-34. DOI: 10.1097/00003446-198205000-00006. View

Rist P, Sesso H, Johnson L, Aragaki A, Wang L, Rautiainen S . Design and baseline characteristics of participants in the COcoa Supplement and Multivitamin Outcomes Study (COSMOS). Contemp Clin Trials. 2022; 116:106728. PMC: 9133193. DOI: 10.1016/j.cct.2022.106728. View

Baumgart M, Snyder H, Carrillo M, Fazio S, Kim H, Johns H . Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective. Alzheimers Dement. 2015; 11(6):718-26. DOI: 10.1016/j.jalz.2015.05.016. View

Grodstein F, OBrien J, Kang J, Dushkes R, Cook N, Okereke O . Long-term multivitamin supplementation and cognitive function in men: a randomized trial. Ann Intern Med. 2014; 159(12):806-14. PMC: 3858850. DOI: 10.7326/0003-4819-159-12-201312170-00006. View

Chester J, Grande L, Milberg W, McGlinchey R, Lipsitz L, Rudolph J . Cognitive screening in community-dwelling elders: performance on the clock-in-the-box. Am J Med. 2011; 124(7):662-9. PMC: 3128995. DOI: 10.1016/j.amjmed.2011.02.023. View

Small B, Fratiglioni L, Viitanen M, Winblad B, Backman L . The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Arch Neurol. 2000; 57(6):839-44. DOI: 10.1001/archneur.57.6.839. View

Suh S, Kim H, Han J, Bae J, Oh D, Han J . Efficacy of Vitamins on Cognitive Function of Non-Demented People: A Systematic Review and Meta-Analysis. Nutrients. 2020; 12(4). PMC: 7231132. DOI: 10.3390/nu12041168. View

10.

Yeung L, Alschuler D, Wall M, Luttmann-Gibson H, Copeland T, Hale C . Multivitamin Supplementation Improves Memory in Older Adults: A Randomized Clinical Trial. Am J Clin Nutr. 2023; 118(1):273-282. PMC: 10375458. DOI: 10.1016/j.ajcnut.2023.05.011. View

11.

Sesso H, Rist P, Aragaki A, Rautiainen S, Johnson L, Friedenberg G . Multivitamins in the prevention of cancer and cardiovascular disease: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial. Am J Clin Nutr. 2022; 115(6):1501-1510. PMC: 9170475. DOI: 10.1093/ajcn/nqac056. View

12.

Morris J, HEYMAN A, Mohs R, Hughes J, van Belle G, Fillenbaum G . The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989; 39(9):1159-65. DOI: 10.1212/wnl.39.9.1159. View

13.

Chiuve S, Fung T, Rimm E, Hu F, McCullough M, Wang M . Alternative dietary indices both strongly predict risk of chronic disease. J Nutr. 2012; 142(6):1009-18. PMC: 3738221. DOI: 10.3945/jn.111.157222. View

14.

Bland J, Altman D . Multiple significance tests: the Bonferroni method. BMJ. 1995; 310(6973):170. PMC: 2548561. DOI: 10.1136/bmj.310.6973.170. View

15.

Albert M, DeKosky S, Dickson D, Dubois B, Feldman H, Fox N . The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7(3):270-9. PMC: 3312027. DOI: 10.1016/j.jalz.2011.03.008. View

16.

McNeill G, Avenell A, Campbell M, Cook J, Hannaford P, Kilonzo M . Effect of multivitamin and multimineral supplementation on cognitive function in men and women aged 65 years and over: a randomised controlled trial. Nutr J. 2007; 6:10. PMC: 1872030. DOI: 10.1186/1475-2891-6-10. View

17.

Grima N, Pase M, Macpherson H, Pipingas A . The effects of multivitamins on cognitive performance: a systematic review and meta-analysis. J Alzheimers Dis. 2012; 29(3):561-9. DOI: 10.3233/JAD-2011-111751. View

18.

Kesse-Guyot E, Fezeu L, Jeandel C, Ferry M, Andreeva V, Amieva H . French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial. Am J Clin Nutr. 2011; 94(3):892-9. DOI: 10.3945/ajcn.110.007815. View

19.

Smith-Warner S, Spiegelman D, Ritz J, Albanes D, Beeson W, Bernstein L . Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol. 2006; 163(11):1053-64. DOI: 10.1093/aje/kwj127. View

20.

Butler M, Nelson V, Davila H, Ratner E, Fink H, Hemmy L . Over-the-Counter Supplement Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review. Ann Intern Med. 2017; 168(1):52-62. DOI: 10.7326/M17-1530. View